Personal profile
Specialisation
Clinical Pharmacology and Pharmacy
Research interests
- PK-PD research in special patient populations, like ICU patients an hematological patients
- Promoting availability of drugs for rare diseases and enhancing knowledge about their optimal dosing
Activities
- Head of the Department of Pharmacy and Clinical Pharmacology AmsterdamUMC
- Chair of the Dutch Society of Clinical Pharmacology and Biopharmacy
- Chair of the Scientific Advisory Board CHDR
- Chair of the Scientific Advisory Board CFK (ZIN)
Fingerprint
Dive into the research topics where Eleonora L. Swart is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Research output
-
A pharmacokinetic study and critical reappraisal of curcumin formulations enhancing bioavailability
Kroon, M. A. G. M., van Laarhoven, H. W. M., Swart, E. L., van Tellingen, O. & Kemper, E. M., 20 Jun 2025, In: iScience. 28, 6, 112575.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile45 Downloads (Pure) -
Challenges in the identification and quantification of an unknown impurity in chenodeoxycholic acid drug substance
Bouwhuis, N., Polak, Y., Schimmel, A. M., Bijleveld, Y. A., Giera, M. A., Heijink, M., Vaz, F. M., Bootsma, A. H., Berg-Lammers, L. A. T., Swart, N. E. L., Hollak, C. E. M., Jacobs, B. A. W. & Kemper, E. M., 1 Feb 2025, In: European journal of pharmaceutical sciences. 205, p. 106979 106979.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile27 Downloads (Pure) -
Disease–Drug–Drug Interaction of Imatinib in COVID-19 ARDS: A Pooled Population Pharmacokinetic Analysis
Said, M. M., Schippers, J. R., Atmowihardjo, L., Li, Y., van der Plas, M. S., Bogaard, H. J., Bos, L. D. J., Mathôt, R. A. A., Aman, J., Swart, E. L. & Bartelink, I. H., Mar 2025, In: CPT: Pharmacometrics and Systems Pharmacology. 14, 3, p. 583-595 13 p.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile22 Downloads (Pure) -
Exposure-response analysis of oral and intravenous imatinib in critically ill patients with COVID-19 acute respiratory distress syndrome
Said, M. M., Braam, A. M., Duijvelaar, E., Schippers, J. R., Atmowihardjo, L., Twisk, J., Bogaard, H. J., Swart, E. L., Aman, J. & Bartelink, I. H., 1 Dec 2025, In: European journal of pharmaceutical sciences. 215, p. 107332 107332.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile28 Downloads (Pure) -
External Cross-validation of Two Ciprofloxacin Population Pharmacokinetic Models in Patients in Intensive Care
Rigter, I. M., Swart, E. L., Brüggemann, R. J., Guo, T., Elbers, P. W. G. & van Hest, R. M., 2025, (E-pub ahead of print) In: Therapeutic drug monitoring.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile35 Downloads (Pure)